元宇宙医学是以扩展现实、物联网、人工智能、数字孪生等技术为核心的医学前沿构想，力图化解当前中国传统医疗模式的困境。但是，相关法律规制的缺乏在客观上限制了元宇宙医学的进一步发展。 从数字孪生这一极具医学潜力的元宇宙技术出发，探讨相关法律的制度应对与价值重构。数字孪生医学应用涉及人权、医事、算法3个侧面，其争议焦点有：知情同意机制待完善、主体范围资格待限定、损害责任归属待明确。从数字孪生医学应用的争议解决，透视元宇宙医学的整体法律规制完善进路。国内组织模式上，应当找到稳定的法益保护内核以建立算法社会的新型法秩序；国际组织模式上，国际公法可以发挥统筹约束机能，建立全球化医学元宇宙。

The metaverse in medicine is a cutting-edge conception in the field of medicine centered on technologies such as virtual reality, the Internet of Things, artificial intelligence, and digital twins, which seeks to resolve the dilemmas of the current situation of healthcare in China. However, the lack of legal regulation has objectively limited further development of metaverse in medicine. Starting from digital twins, a representative technology with great potential in this field, we discuss the institutional response and value reconstruction of related laws. The medical application of digital twins involves human rights, medical affairs and algorithms. How to improve informed consent mechanism, how to limit subject scope qualification, and how to clarify damage responsibility attribution together contribute the key issues in resolving the controversies. From the dispute resolution of digital twin medicine application, we can conclude an improvement approach of the overall legal regulation of metaverse in medicine. On the domestic organization mode, a stable legal interest protection core should be found to establish a new legal order of the algorithmic society. On the international organization mode, the public international law can play a coordinating and restraining function to establish a globalized medical metaverse.